Mistletoe Extracts Standardised in terms of Mistletoe Lectins (ML I) in Oncology: Current State of Clinical Research
暂无分享,去创建一个
[1] H. Franz. Inhaltsstoffe der Mistel (Viscum album L.) als potentielle Arzneimittel , 1985 .
[2] D. Lenartz,et al. Immunoprotective activity of the galactoside-specific lectin from mistletoe after tumor destructive therapy in glioma patients. , 1996, Anticancer research.
[3] J. Jeljaszewicz,et al. Thymocyte proliferation and maturation in response to galactoside-specific mistletoe lectin-1. , 1993, In vivo.
[4] R. Saller,et al. Effect of a Recombinant Lectin, Viscum album Agglutinin on the Secretion of Interleukin-12 in Cultured Human Peripheral Blood Mononuclear Cells and on NK-Cell-Mediated Cytotoxicity of Rat Splenocytes in vitro and in vivo , 1998, Natural Immunity.
[5] D. Lenartz,et al. Survival of glioma patients after complementary treatment with galactoside-specific lectin from mistletoe. , 2000, Anticancer research.
[6] H. Lentzen,et al. Effects of a standardized mistletoe preparation on metastatic B16 melanoma colonization in murine lungs. , 1998, Arzneimittel-Forschung.
[7] H. Franz,et al. The site of action of the A‐chain of mistletoe lectin I on eukaryotic ribosomes The RNA N‐glycosidase activity of the protein , 1988, FEBS letters.
[8] M. Krul. Fifth NCI-EORTC Symposium on New Drugs in Cancer Therapy , 1986, Medical Oncology and Tumor Pharmacotherapy.
[9] H. Lentzen,et al. Stimulation of neutropoiesis by a special standardized mistletoe preparation after cyclophosphamide chemotherapy in mice. , 1996, Arzneimittel-Forschung.
[10] H. Friess,et al. Treatment of advanced pancreatic cancer with mistletoe: results of a pilot trial. , 1996, Anticancer research.
[11] J. Beuth,et al. Mistletoe extract standardized for the galactoside-specific lectin (ML-1) induces beta-endorphin release and immunopotentiation in breast cancer patients. , 1994, Anticancer research.
[12] H. Gabius,et al. Behavior of lymphocyte subsets and expression of activation markers in response to immunotherapy with galactoside-specific lectin from mistletoe in breast cancer patients , 1992, The clinical investigator.
[13] K. Frei,et al. Increased Secretion of Tumor Necrosis Factor α, Interleukin 1, and Interleukin 6 by Human Mononuclear Cells Exposed to β-Galactoside-specific Lectin from Clinically Applied Mistletoe Extract , 1990 .
[14] E. Koch. Experimentelle Untersuchungen über entzündung- und nekroseerzeugende Wirkung von Viscum album , 1938 .
[15] J. Beuth,et al. Correlation of immune cell activities and beta-endorphin release in breast carcinoma patients treated with galactose-specific lectin standardized mistletoe extract. , 1998, Anticancer research.
[16] J. Kleijnen,et al. Mistletoe treatment for cancer review of controlled trials in humans. , 1994, Phytomedicine.
[17] H. Gabius,et al. Influence of treatment with the immunomodulatory effective dose of the beta-galactoside-specific lectin from mistletoe on tumor colonization in BALB/c-mice for two experimental model systems. , 1991, In vivo.
[18] T. Lenarz,et al. The effect of an adjuvant mistletoe treatment programme in resected head and neck cancer patients: a randomised controlled clinical trial. , 2001, European journal of cancer.
[19] kolorektalen Karzinom,et al. Lebensqualitätsstabilisierung durch Mistellektin-1 normierten Extrakt beim fortgeschrittenen kolorektalen Karzinom , 1998, Der Onkologe.
[20] J. Beuth,et al. [Immunoactive effects of various mistletoe lectin-1 dosages in mammary carcinoma patients]. , 1995, Arzneimittel-Forschung.
[21] U. Mengs,et al. Antitumoral effects of an intravesically applied aqueous mistletoe extract on urinary bladder carcinoma MB49 in mice. , 2000, Anticancer research.
[22] H. Gabius,et al. Clinical application of various plant and endogenous lectins to leukemia , 1988, Blut.
[23] B.-M. Heiný,et al. KOMPLEMENTARE THERAPIE MIT MISTELLEKTIN-1-NORMIERTEM EXTRAKT : LEBENSQUALITATSTABILISIERUNG BEIM FORTGESCHRITTENEN KOLOREKTALEN KARZINOM : FAKT ODER F IKTION ? , 1997 .